نتایج جستجو برای: vaccine efficacy

تعداد نتایج: 405191  

Journal: :Infection Control & Hospital Epidemiology 1999

Journal: :Canadian Medical Association Journal 2009

2000
Derek J. Smith Jan C. deJong Ron A. M. Fouchier Alan S. Perelson

Background: The accumulated wisdom is to update the vaccine strain to the expected epidemic strain only when there is at least a 4-fold difference [measured by the hemagglutination inhibition (HI) assay] between the current vaccine strain and the expected epidemic strain. In this study we investigate the effect, on repeat vaccinees, of updating the vaccine when there is a less than 4-fold diffe...

Amir Teimourpour Hadi peeridogaheh Mohsen Arzanlou Roghayeh Teimourpour, Zahra Meshkat,

Objective(s): Tuberculosis (TB) has still remained a global health issue. One third of the world's population is infected with tuberculosis and the current BCG vaccine has low efficiency; hence, it is necessary to develop a new vaccine against TB. The aim of the current study was to evaluate the efficiency of a novel DNA vaccine encoding Mtb32C-HBHA antigen in inducing specific immune responses...

Journal: :Lancet 2007
Jorma Paavonen David Jenkins F Xavier Bosch Paulo Naud Jorge Salmerón Cosette M Wheeler Song-Nan Chow Dan L Apter Henry C Kitchener Xavier Castellsague Newton S de Carvalho S Rachel Skinner Diane M Harper James A Hedrick Unnop Jaisamrarn Genara Am Limson Marc Dionne Wim Quint Bart Spiessens Pascal Peeters Frank Struyf Susan L Wieting Matti O Lehtinen Gary Dubin

BACKGROUND The aim of this interim analysis of a large, international phase III study was to assess the efficacy of an AS04 adjuvanted L1 virus-like-particle prophylactic candidate vaccine against infection with human papillomavirus (HPV) types 16 and 18 in young women. METHODS 18,644 women aged 15-25 years were randomly assigned to receive either HPV16/18 vaccine (n=9319) or hepatitis A vacc...

Journal: :PLoS Neglected Tropical Diseases 2009
A. Desiree LaBeaud Indu Malhotra Maria J. King Christopher L. King Charles H. King

On a global basis, both potent vaccine efficacy and high vaccine coverage are necessary to control and eliminate vaccine-preventable diseases. Emerging evidence from animal and human studies suggest that neglected tropical diseases (NTDs) significantly impair response to standard childhood immunizations. A review of efficacy and effectiveness studies of vaccination among individuals with chroni...

Journal: :The Journal of infectious diseases 2008
Suzanne E Ohmit John C Victor Esther R Teich Rachel K Truscon Judy R Rotthoff Duane W Newton Sarah A Campbell Matthew L Boulton Arnold S Monto

BACKGROUND The efficacy of influenza vaccines may vary annually. In 2004-2005, when antigenically drifted viruses were circulating, a randomized, placebo-controlled trial involving healthy adults showed that inactivated vaccine appeared to be efficacious, whereas live attenuated vaccine appeared to be less so. METHODS In 2005-2006, we continued our trial, examining the absolute and relative e...

2017
Allan C deCamp Morgane Rolland Paul T Edlefsen Eric Sanders-Buell Breana Hall Craig A Magaret Andrew J Fiore-Gartland Michal Juraska Lindsay N Carpp Shelly T Karuna Meera Bose Steven LePore Shana Miller Annemarie O'Sullivan Kultida Poltavee Hongjun Bai Kalpana Dommaraju Hong Zhao Kim Wong Lennie Chen Hasan Ahmed Derrick Goodman Matthew Z Tay Raphael Gottardo Richard A Koup Robert Bailer John R Mascola Barney S Graham Mario Roederer Robert J O'Connell Nelson L Michael Merlin L Robb Elizabeth Adams Patricia D'Souza James Kublin Lawrence Corey Daniel E Geraghty Nicole Frahm Georgia D Tomaras M Juliana McElrath Lisa Frenkel Sheila Styrchak Sodsai Tovanabutra Magdalena E Sobieszczyk Scott M Hammer Jerome H Kim James I Mullins Peter B Gilbert

Although the HVTN 505 DNA/recombinant adenovirus type 5 vector HIV-1 vaccine trial showed no overall efficacy, analysis of breakthrough HIV-1 sequences in participants can help determine whether vaccine-induced immune responses impacted viruses that caused infection. We analyzed 480 HIV-1 genomes sampled from 27 vaccine and 20 placebo recipients and found that intra-host HIV-1 diversity was sig...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999
U Heininger K Stehr P Christenson J D Cherry

A subanalysis of a recent cohort efficacy trial of a pertussis vaccine was performed to determine its efficacy against cough illnesses due to Bordetella parapertussis infections. Infants received four doses of either the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis (DTaP) vaccine or the Lederle whole-cell component diphtheria and tetanus toxoids and ...

Journal: :The New England journal of medicine 2010
Neil French Stephen B Gordon Thandie Mwalukomo Sarah A White Gershom Mwafulirwa Herbert Longwe Martin Mwaiponya Eduard E Zijlstra Malcolm E Molyneux Charles F Gilks

BACKGROUND Streptococcus pneumoniae is a leading and serious coinfection in adults with human immunodeficiency virus (HIV) infection, particularly in Africa. Prevention of this disease by vaccination with the current 23-valent polysaccharide vaccine is suboptimal. Protein conjugate vaccines offer a further option for protection, but data on their clinical efficacy in adults are needed. METHOD...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید